assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
Published 4 months ago • 71 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
2:20
quantifying the anemia benefit of momelotinib in mf: analysis of data from simplify-1 & simplify-2
-
1:24
updated results from the momentum study assessing the efficacy of momelotinib in mf
-
1:45
momelotinib vs soc in patients with mf and anemia: an analysis from the simplify-2 trial
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
5:12
dengue fever with dr. joseph alton md
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
3:43
momelotinib: a promising drug for patients with myelofibrosis
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes
-
2:20
momentum & the potential impact of approval of momelotinib in myelofibrosis
-
3:02
latest updates on momelotinib: safety, durability of response & survival benefit
-
2:48
updated results from the momentum trial